
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Crescent city cooks up culinary cuisineHave no reservations about choosing to dine in Big EasyHave no reservations about choosing to dine in Big Easy